- Papers in database
- 6
- Primary author
- 3 papers
- Years active
- 2010 – 2019
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (6)
- 2019Primary authorLactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.10.1152/ajpgi.00107.2019
- 2018Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.10.1152/ajpgi.00084.2017
- 2017Lactobacillus reuteri for Infants with Colic: A Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial10.1016/j.jpeds.2017.07.036
- 2012Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial10.1371/journal.pone.0043910
- 2012Primary authorLactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine.10.1152/ajpgi.00266.2011
- 2010Primary authorHuman-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.10.1152/ajpgi.00124.2010